Phio Pharmaceuticals (PHIO) Annual Balance Sheets

Annual · GAAP · USD millions
Access PHIO quarterly Balance Sheets →
Examining balance sheet movements between Phio Pharmaceuticals and Dec 31 2021 reveals how Dec 31 2025 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent21.03
Cash & Short-term Investments21.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.45
Total Current Assets21.48
Equipment/Property/Plant Net0.01
Other Assets, Noncurrent0.00
Restricted Cash-
Operating Lease Right Of Use Asset-
Total Assets21.49
Liabilities
Accounts Payable, Current AC0.44
Accrued Liabilities, Current AC0.91
Other Liabilities, Current0.00
Total Current Liabilities1.34
Total Long-term Debt0.00
Other liabilities, Noncurrent1.34
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current-
Total Liabilities1.34
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock175.20
Retained Earnings / Accumulated Deficit-155.05
Other Equity0.00
Common Stockholder's Equity20.15
Non-controlling interests & other0.00
Total Stockholder's Equity20.15
Liabilities & Stockholder's Equity21.49
4 historic quarters locked

Sign in to unlock the full Phio Pharmaceuticals balance sheet history.

About Phio Pharmaceuticals Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-007078

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.